logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5127.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5127.produseast1
12-month post-treatment outcomes of previously treated drug-resistant tuberculosis patients subsequently treated with concomitant bedaquiline and delaminid +/- carbapenem, in Mumbai, India | Conference Material / Video | MSF Science Portal
Conference Material
|Video

12-month post-treatment outcomes of previously treated drug-resistant tuberculosis patients subsequently treated with concomitant bedaquiline and delaminid +/- carbapenem, in Mumbai, India

Chavan V

Similar Content
Poster
|Poster
12-month post-treatment outcomes of previously treated drug-resistant tuberculosis patients subsequently treated with concomitant bedaquiline and delamanid +/-carbapenem, in Mumbai, India
2024 November 08 • MSF Scientific Days Asia 2024
Loading...
Loading...

Countries

India

Subject Area

tuberculosis

Languages

English
Published Date
24 Oct 2024
Conference
MSF Scientific Days Asia 2024
Linked Content
Conference Material
|Poster
12-month post-treatment outcomes of previously treated drug-resistant tuberculosis patients subsequently treated with concomitant bedaquiline and delamanid +/-carbapenem, in Mumbai, India
2024 November 08 • MSF Scientific Days Asia 2024